PhaseBio Pharmaceuticals Inc (PHAS)

NASDAQ
Currency in USD
0.070
-0.025(-26.21%)
Real-time Data

PHAS Income Statement

Advanced Income Statement
Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa10.83
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3,284.69%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa102.11
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa-91.28
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-27.18%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-842.73%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa16.09
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-107.36
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-26.52%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-991.25%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-0.93
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+22.76%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-0.95
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa0.01
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-21.18
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-129.47
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-129.47
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-31.36%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-1,195.37%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1.6
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-131.07
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-131.07
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-32.98%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-1,210.15%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-131.07
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-2.98
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.02%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-2.98
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.02%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa43.92
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa43.92
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-105.57
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-25.16%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-974.69%
EBIT
aa.aaaa.aaaa.aaaa.aa